Genesee Capital Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 10.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,091 shares of the healthcare conglomerate’s stock after purchasing an additional 101 shares during the quarter. Genesee Capital Advisors LLC’s holdings in UnitedHealth Group were worth $552,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in the stock. International Assets Investment Management LLC increased its stake in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Accredited Investors Inc. raised its stake in UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares in the last quarter. Raymond James & Associates increased its holdings in shares of UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after purchasing an additional 587,088 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its position in UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after buying an additional 581,324 shares in the last quarter. Finally, State Street Corp raised its position in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Down 0.2 %
UnitedHealth Group stock opened at $542.52 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $499.27 billion, a P/E ratio of 35.00, a P/E/G ratio of 1.41 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm’s fifty day simple moving average is $540.11 and its 200-day simple moving average is $565.06.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is presently 54.19%.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on UNH. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Finally, UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $629.32.
Get Our Latest Research Report on UNH
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- What Does the Future Hold for Eli Lilly?
- How to Plot Fibonacci Price Inflection Levels
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.